ENTITY

Decoy Therapeutics (DCOY US)

3
Analysis
Health Care • United States
Decoy Therapeutics Inc. operates as a preclinical-stage biotechnology company. The Company specializes in drug development and manufacturing peptide conjugate therapeutics that focuses on respiratory viruses and GI cancers. Decoy Therapeutics serves customers in the United States.
more
Company Event • 11 Nov 2026 05:00 • Upcoming
Add To Calendar

Q3 2026

Company Event • 07 Oct 2026 20:00 • Upcoming
Add To Calendar

Registration filing

Company Event • 01 Oct 2026 23:30 • Upcoming
Add To Calendar

Small cap showcase Conference

Company Event • 12 Aug 2026 19:00 • Upcoming
Add To Calendar

Q2 2026

Company Event • 04 Aug 2026 20:00 • Upcoming
Add To Calendar

Proxy filing

x